Skip to content
Go To Homepage
  • Products
    • Oncology
    • Prenatal
  • Our Technology
    • Technology
    • Publications
  • Careers
    • Working with Us
    • Open Positions
  • News & Media
    • Press Releases
    • Media Coverage
    • Events
    • Social Media
  • About Us
    • Mission, Vision, Values
    • Leadership & Board
    • Company Milestones
  • Contact
abstract pattern of dots and lines

News & Media

General Information

October 31, 2022

CA Superior Court Halts CDPH’s Exclusivity of Trisomy Screening Through the CA PNS Program

Read

Press Releases

September 30, 2022

BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen

Read

Media Coverage

August 4, 2022

BillionToOne Ranked a Top Healthcare Technology Company of 2022

Read

Press Releases

July 8, 2022

BillionToOne launches oncology liquid biopsy products for research use & announces clinical research collaboration with UCSD

Read

Media Coverage

March 30, 2022

BillionToOne Closes $125M Series C Funding with Premier Global Investors

Read

Media Coverage

February 17, 2022

BillionToOne CEO Oguzhan Atay, PhD, named in Top 25 CEOs in Biotech of 2022 by the Healthcare Technology Report

Read

Follow Us

  • LinkedIn
  • Twitter

See Recent Social Posts

Social Posts

Get more news sent directly to your inbox.

Newsletter(Required)
This field is for validation purposes and should be left unchanged.
Go To Homepage

We are ONE team, working
toward ONE goal – to detect
disease ONE molecule at a time.

CAP Accredited College of American Pathologists

  • What We Offer
  • Our Technology
  • Publications
  • Products
  • Explore
  • News & Media
  • Press Releases
  • Media Coverage
  • Events
  • Social Media
  • About Us
  • Careers
  • Patient Portal
  • IT Security Compliance
  • Contact
  • Contact Information
  • Privacy Policy
  • Notice of Privacy Practices
  • Accessibility Statement
  • TERMS OF USE

ACCREDITATIONS UNION CITY: CA: 00353741 | CAP: 8643216 | CLIA: 05D2167800 | MD: 2999 | PA: 37021 | RI: LCO01671 | DC: OS29 | NYSDOH: 9828

ACCREDITATIONS MENLO PARK: CA: 90008579  | CAP: 9568790  | DC: OS43 | MD: 3855  | CLIA: 05D2275351  | RI: LCO01700  | PA: 40795

PATENT MARKINGS

© 2025 BillionToOne Inc.
All rights reserved.